Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over timeEarly relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time, Published online: 16 November 2017; doi:10.1038/leu.2017.331

Source: Leukemia - November 16, 2017 Category: Hematology Authors: S K Kumar A Dispenzieri R Fraser F Mingwei G Akpek R Cornell M Kharfan-Dabaja C Freytes S Hashmi G Hildebrandt L Holmberg R Kyle H Lazarus C Lee J Mikhael T Nishihori J Tay S Usmani D Vesole R Vij B Wirk A Krishnan C Gasparetto T Mark Y Nieto P Hari A D â Source Type: research